Buying Surgical Robots: Who Makes the Decision and Who Pays?
NHS approval pathways, supplier selection, procurement rules and the long-term commitments behind robotic surgery investment.
In this briefing
Introduction
No single body decides whether an NHS trust buys a surgical robot. NHS England’s call-off guidance says accountability for procurement decisions rests with the contracting authority.1 The implementation guide says plans should be endorsed by regional partners, with a full business case approved before a programme begins.2 NICE sets conditions on the technologies that can be used while evidence is gathered.3
Part 1 examined the commitments made when a trust selects a platform; Part 2 examined the financial assumptions behind that choice. This briefing follows the decision through regulatory eligibility, regional planning, procurement and contract award, then asks what happens when the equipment is operating and the assumptions are tested.
The regulator and the evidence body
The Medicines and Healthcare products Regulatory Agency (MHRA) sets the conditions on which a device can reach the Great Britain market. CE-marked devices continue to be accepted on the Great Britain market under transitional arrangements until 30 June 2028 or 30 June 2030, at the latest, depending on the device,4 and in February 2026 the MHRA opened a consultation, closing on 10 April 2026, on recognising CE-marked devices indefinitely.5 Those are dates for placing devices on the market, not dates by which installed systems must be withdrawn. Part 1 set out the NICE and framework dates. The regulator adds another.
The July 2025 government response announced international reliance routes, still to be introduced, for devices approved by trusted regulators in Australia, Canada and the United States.6 The 2026 consultation proposes a further route for CE-marked devices that fall into a…
Continue with membership
The rest of this briefing is available to active CPO Insights members.
This briefing reflects the author's analysis and understanding of the market, based on professional experience and information available at the time of publication. It is provided for information and discussion and is not legal, financial, investment or other professional advice. Full disclaimer.